Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming

Mark Rusznak(Vanderbilt University Medical Center), R. Stokes Peebles(VA Tennessee Valley Healthcare System), Allison E. Norlander(Tulane University), Justin Jacobse(Leiden University Medical Center), Weisong Zhou(Vanderbilt University Medical Center), Jeremy A. Goettel(Vanderbilt University Medical Center), Shinji Toki(Vanderbilt University Medical Center), Shelby N Kuehnle(Vanderbilt University Medical Center), Masako Abney(Pulmonary and Allergy Associates), Daniel P. Cook(Institute of Molecular Biology and Biophysics), Dawn C. Newcomb(Vanderbilt University), Catherine Dupuy(Vanderbilt University Medical Center), Darla R. Miller(Roswell Park Comprehensive Cancer Center), Matthew T. Stier(Vanderbilt University Medical Center), Liddy Malone(Vanderbilt University Medical Center), Jacqueline-Yvonne Cephus(Pulmonary and Allergy Associates), Rachel Lynch(University of North Carolina at Chapel Hill), Jing Li(Vanderbilt University Medical Center), Andrew P Pahnke(Vanderbilt University Medical Center), Yan Fang(Vanderbilt University), Yajing B. Hao(University of North Carolina at Chapel Hill), Fei Zou(University of North Carolina at Chapel Hill), Christopher M. Thomas(Vanderbilt University Medical Center), M. Wade Calcutt(Vanderbilt University), Dominique Babin(Vanderbilt University Medical Center), Julia F. Goodhead(Vanderbilt University Medical Center), Marc J. C. Todd(Vanderbilt University Medical Center), Mark I. Petrovic(Vanderbilt University Medical Center), Christian M. Warren(VA Tennessee Valley Healthcare System)
Nature Communications
January 3, 2026
Cited by 3


Related Papers